Archives
Novo Nordisk CEO Faces Investigation After Senate Reveals Ozempic and Wegovy Cost Up to 13 Times More in the US
Novo Nordisk CEO Lars Fruergaard Jørgensen will face a Senate hearing over the high prices of weight loss drugs Wegovy and Ozempic in the US.
Genetic Testing Giant 23andMe Loses Entire Board Over CEO’s Privatization Plans
23andMe’s board directors resigned as CEO Anne Wojcicki pushed to take the company private, while concerns remain over its financial struggles, privacy issues, and unresolved lawsuits.
Huawei's $2,800 Trifold Phone Gains Popularity in China Even Among Apple Loyalists
Huawei’s new trifold phone is gaining interest from Apple fans in Beijing due to its innovative design, even though it is more expensive than the iPhone 16.
Global Stocks Near Record Highs as Fed Cuts Interest Rates
Global stocks are reaching record highs following recent interest rate cuts, while the Japanese yen weakened as the Bank of Japan opted not to raise rates, contrasting with trends in the US and UK.

















